Ed Ho LAB International LAB-T TOP PICK Mar 24, 2004

Changing from a clinical research organization to a product company. Good management. Very cheap.

Ed Ho

Owned

Unlock Rating

$1.150

Stock price when the opinion was issued

biotechnology pharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

WEAK BUY

Down 13% year-to-date and 8% on a 52-week basis. Did some acquisitions in October. Revenues have been flat year on year. Not much margin. Volume can be thin. Looks like it has made a turn. Risky.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Ed Ho LAB International LAB-T TOP PICK Mar 24, 2004

You might be interested:

LAB International(LAB-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Richard Fogler

The Panic-Proof Portfolio (Stockchase Research)

Andrew Pink

Stockchase Insights

Jim Cramer - Mad Money